Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

NCT00842829 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

330

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment stopped at the end of the recruitment timeframe

Conditions

Cancer Pain
Breakthrough Pain

Interventions

DRUG: Fentanyl Buccal Tablet (FBT)

Sponsor

Cephalon